Helene Favre

Helene Favre, PhD, currently serves as a Clinical Trial Manager at Alector since January 2022 and has been a Clinical Research Associate II at Plexxikon Inc. since May 2016, assisting in the oversight and management of early-phase clinical trials for solid tumors and advanced malignancies. Previously, Helene held the position of Associate Clinical Study Manager at BeiGene, overseeing a global Phase 3 trial for the anti-PD-1 antibody Tislelizumab in patients with hepatocellular carcinoma, and served as a Clinical Research Coordinator at UCSF Medical Center, managing studies related to fibrodysplasia ossificans progressiva. Helene's earlier roles include Analyst at the UCSF Diabetes Center, Project Manager in the UCSF Pediatrics Department, and Project Manager/Associate Specialist at the UCSF Diabetes Center, focusing on neuro-endocrinology and molecular biology research. Helene's academic background includes a PhD in Endocrinology and Molecular Biology from Paris-Sud University (Paris XI) and additional qualifications in Clinical Trials Design and Management and Data Management for Clinical Research.